Company: NGVT
Filing Date: 2025-03-10
Form Type: PREC14A
Source: 0001308179-25-000061
Chunk: 47

Company: Ingevity Corp
Filing Date: 2025-03-10
Form: PREC14A
Chunk 47
---
 $12,166. Ms. Hall received relocation benefits in 2024 in the amount of $6,845, including a tax-gross up of $2,047 related to her move to permanent housing during 2023. Certain reimbursable expenses related to the closing of her home purchase in late 2023 were reimbursed to Ms. Hall during 2024. These relocation benefits paid to Mr. Fernandez-Moreno and Ms. Hall are reflected in “All Other Compensation” in the Summary Compensation Table and were paid pursuant to the Company’s broad-based relocation policy that covers all Company salaried employees. No other relocation benefits were provided to a NEO during 2024. We also provide limited other benefits to our executives, including our NEOs, to promote their security and well-being, thereby allowing them to focus on Company business. Other benefits paid to NEOs in 2024 include financial counseling and executive physicals. The value of the benefits is credited to the NEOs as imputed income. Other than with respect to relocation benefits, the Company does not provide any tax gross-ups. In addition, NEOs participate in each of the benefit plans or arrangements that generally are made available to all U.S.-based salaried employees, including vacation benefits, medical and dental benefits, and life, accidental death and disability insurance.

| INGEVITY  |  2025 
 Proxy Statement   | 65 |

Compensation Discussion and Analysis Risk analysis Risk analysis At least annually, the T&C Committee reviews Ingevity’s executive and non-executive compensation programs to assess whether they encourage or create excessive risk-taking not in the best interest of the Company or its stockholders. The most recent assessment occurred in October 2024. In conducting this assessment, the T&C Committee reviewed various components and design features of all of the Company’s executive and non-executive plans and programs as presented by management and the Compensation Consultant and analyzed them in the context of risk mitigation. Management and the Compensation Consultant presented their conclusions to the T&C Committee, which were that Ingevity’s compensation arrangements are not constructed or administered in a way that is likely to create risks that could materially and adversely affect the Company. Among the factors considered in the assessment and reviewed by the T&C Committee were:

| n | the balance of the Company’s overall program design, including the mix of cash and equity compensation;                       |
| n | the mix of fixed and variable compensation;                                                                                   |
| n | the balance of short-term and